RP
Rodolfo Perini
Hematology & Oncology
Credentials: ·
History
Hematology and Medical Oncology
Internal Medicine
Research
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
New England Journal of Medicine · 2017 · 2,802 citations
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2019 · 2,745 citations
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
New England Journal of Medicine · 2021 · 1,467 citations
23 papers
- RM
15 papers
12 papers
10 papers
9 papers
8 papers
8 papers
7 papers
